Non-invasive assessment of liver steatosis in non-alcoholic fatty liver disease

Hepatology Research

Volumn 44, Issue 14, 2014, Pages E420-E427

  Kan, Hiromi ^a   Kimura, Yuki ^b   Hyogo, Hideyuki ^a   Fukuhara, Takayuki ^a   Fujino, Hatsue ^a   Naeshiro, Noriaki ^a   Honda, Yohji ^a   Kawaoka, Tomokazu ^a   Tsuge, Masataka ^a   Hiramatsu, Akira ^a   Imamura, Michio ^a   Kawakami, Yoshiiku ^a   Aikata, Hiroshi ^a   Ochi, Hidenori ^a   Arihiro, Koji ^a   Chayama, Kazuaki ^a  

^a HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Liver to spleen ratio; Non alcoholic fatty liver disease; Non invasive assessment; Steatotic grade

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; GAMMA GLUTAMYLTRANSFERASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASSESSMENT OF HUMANS; BODY MASS; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HISTOPATHOLOGY; HOMEOSTASIS MODEL OF ASSESSMENT INSULIN RESISTANCE; HUMAN; HUMAN TISSUE; LIPID STORAGE; LIVER BIOPSY; LIVER SPLEEN RATIO; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NONALCOHOLIC FATTY LIVER; PREDICTIVE VALUE; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; SENSITIVITY AND SPECIFICITY;

EID: 84918592392     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/hepr.12330     Document Type: Article

References (29)

1. Younossi ZM, Stepanova M, Afendy M etal. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 2011; 9: 524-530.
2. Hamaguchi M, Kojima T, Takeda N etal. Themetabolic syndrome as a predictor of noalcoholic fatty liver disease. Ann Intern Med 2005; 143: 722-728.
3. Kojima S, Watanabe N, Numata M etal. Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. J Gastroenterol 2003; 38: 954-961.
4. Amarapurkar DN, Hashimoto E, Lesmana LA etal. Asia-Pacific Working Party on NAFLD. How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? J Gastroenterol Hepatol 2007; 22: 788-793.
5. Okanoue T, Umemura A, Yasui K etal. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in Japan. J Gastroenterol Hepatol 2011; 26: 153-162.
6. Eguchi Y, Hyogo H, Ono M etal. Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study. J Gastroenterol 2012; 47: 586-595.
7. Teli MR, James OF, Burt AD etal. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 1995; 22: 1714-1719.
8. Dam-Larsen S, Franzmann M, Andersen IB etal. Long term prognosis of fatty liver: risk of chronic liver disease and death. Gut 2004; 53: 750-755.
9. Matteoni CA, Younossi ZM, Gramlich T etal. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-1419.
10. James O, Day C. Non-alcoholic steatohepatitis: another disease of affluence. Lancet 1999; 353: 1634-1636.
11. Negro F, Clement S. Impact of obesity, steatosis and insulin resistance on progression and response therapy of hepatitis C. J Viral Hepat 2009; 16: 681-688.
12. Masaki K, Takaki S, Hyogo H etal. Utility of controlled attenuation parameter measurement for assessing liver steatosis in Japanese patients with chronic liver diseases. Hepatol Res 2013; 43: 1182-1189.
13. Piekarski J, Goldberg HI, Royal SA etal. Difference between liver and spleen CTnumbers in the normal adult: its usefulness in predicting the presence of diffuse liver disease. Radiology 1980; 137: 727-729.
14. Ricci C, Longo R, Gioulis E etal. Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol 1997; 27: 108-113.
15. Park SH, Kim PN, Kim KW etal. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology 2006; 239: 105-112.
16. Iwasaki M, Takada Y, Tanaka K etal. Noninvasive evaluation of graft steatosis in living donor liver transplantation. Transplantation 2004; 78: 1501-1505.
17. The World Medical Association, Inc. Declaration of Helsinki; Ethical Principle for Medical Research Involving Human Subject. Seoul: WMA General Assembly, 2008.
18. Iwamoto K, Kanno K, Hyogo H etal. Advanced glycation end products enhance the proliferation and activation of hepatic stellate cells. J Gastroenterol 2008; 43: 298-304.
19. Matthews DR, Hosker JP, Rudenski AS etal. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
20. Brunt EM, Janney CG, Di Bisceglie AM etal. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 2467-2474.
21. Kleiner DE, Brunt EM, Van Natta M etal. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-1321.
22. Ohnishi M, Tsuge M, Chayama K etal. IL28B polymorphism is associated with fatty change in the liver of chronic hepatitis C patients. J Gastroenterol 2012; 47: 834-844.
23. Hyogo H, Iwamoto K, Arihiro K etal. Elevated levels of serum advanced glycation end productsin patients with nonalcoholic steatohepatitis. J Gastroenterol Hepatol 2007; 22: 1114-1119.
24. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006; 43: 99-112.
25. Schwenzer NF, Springer F, Schraml C etal. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol 2009; 51: 433-445.
26. Charatcharoenwitthaya P, Lindor KD. Role of radiologic modalities in the management of non-alcoholic steatohepatitis. Clin Liver Dis 2007; 11: 37-54.
27. Goldaracena N, Quinonez E, Mendez P etal. Extremely marginal liver grafts from deceased donors have outcome similar to ideal grafts. Transplant Proc 2012; 44: 2219-2222.
28. Saadeh S, Younossi ZM, Remer EM etal. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 745-750.
29. Oliva MR, Mortele KJ, Segatto E etal. Computed tomography features of nonalcoholic steatohepatitis with histopathologic correlation. J Comput Assist Tomogr 2006; 30: 37-43.